Yahoo Suche Web Suche

Anmelden

Suchergebnisse

  1. Suchergebnisse:

  1. en.wikipedia.org › wiki › Barinthus_BiotherapeuticsBarinthus Biotherapeutics - Wikipedia

    Barinthus Biotherapeutics plc (formerly Vaccitech plc) is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. [1] [2] Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus ...

  2. www.finanzen.net › aktien › vaccitech_1-aktieVACCITECH AKTIE | Aktienkurs | US91864C1071 | News | A3CN5Q -...

    VACCITECH AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Vaccitech PLC (spons. ADRs) | A3CN5Q | BRNS | US91864C1071.

  3. www.ft.com › content › 2d40c755-81f7/4162/93bb-388e22b53514Vaccitech chief confident of beating mRNA in cancer treatment

    21. Juni 2021 · Vaccitech is entering trials to treat lung and prostate cancer this year, while rivals BioNTech and Moderna have been developing cancer medicines using mRNA. They all hope to use the new ...

  4. www.welt.de › wirtschaft › article230141185Vaccitech: Der Briten-Stolz bevorzugt für Börsenstart die USA

    11. Apr. 2021 · Vaccitech: Der Briten-Stolz bevorzugt für Börsenstart die USA. Vaccitech ist der ganze Stolz der Inselnation. Das Unternehmen hat gemeinsam mit der Universität Oxford und dem Pharmakonzern ...

  5. www.deraktionaer.de › artikel › pharma-biotechVaccitech: AstraZenecas Impfstoff-Partner plant Börsengang

    12. Apr. 2021 · Impfstoff. Das britische Biotechnologie-Start-up Vaccitech strebt einen Börsengang an der Nasdaq an. Das Unternehmen steht hinter dem COVID-19-Impfstoff des Pharmakonzerns AstraZeneca und peilt...

    • Benjamin Heimlich

  6. de.linkedin.com › company › vaccitech-plcVaccitech | LinkedIn

    Vaccitech is a clinical stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. The company’s proprietary technology platform, comprising...

  7. www.ft.com › content › 22f65d88-b3e3-4162-bef7-d94d0b5a5618Biotech start-up behind AstraZeneca jab raises $168m - Financial...

    17. März 2021 · The Oxford start-up Vaccitech that owns the biotech platform behind the AstraZeneca Covid-19 vaccine has raised $168m, as it seeks to use similar technology to treat other infectious diseases and ...